디지털 병리학 시장 보고서 : 제품 유형별, 딜리버리 모델별, 용도별, 최종 사용자별, 지역별(2024-2032년)

The global digital pathology market size reached US$ 937.8 Million in 2023. Looking forward, IMARC Group expects the market to reach US$ 2,082.7 Million by 2032, exhibiting a growth rate (CAGR) of 9% during 2024-2032.

Digital pathology (DP) is a dynamic and image-based system that facilitates acquisition, management and interpretation of information related to human and animal pathology. It processes digital data through scanners, information management systems, storage devices, visualizing software and web and cloud-based communication systems. The DP systems analyze high-resolution samples and store digital slides on a server or the cloud. This enables the pathologists to cross-examine slides in the absence of physical evidence. They also aid in minimizing costs and improving the accuracy of the test results. Consequently, they find extensive application in teleconsultation, disease diagnosis and drug discovery across the educational, medical and pharmaceutical industries.

Global Digital Pathology Market

The rising trend of digitization, along with the increasing adoption of telepathology across the globe, is one of the key factors driving the growth of the market. Telepathology aids in faster and efficient disease diagnosis and ease in consultation, owing to which it is rapidly being incorporated across various healthcare and diagnostic centers. Furthermore, the rising prevalence of chronic medical ailments, such as cancer, is also providing a boost to the market growth. Additionally, various technological advancements, including the integration of Laboratory Information Systems (LIS) and the introduction of digital imaging, robotic light microscopy and multiple fiber-optic communications, are impacting the market positively. Other factors, including rising geriatric population and extensive research and development (R&D) activities in the pharmaceutical and bioscience sectors, are projected to drive the market further.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global digital pathology market report, along with forecasts at the global, regional and country level from 2024-2032. Our report has categorized the market based on product, type, delivery model, end-user and application.

Breakup by Product:

Scanners

Software

Storage Systems

Communication Systems

Breakup by Type:

Human Pathology

Veterinary Pathology

Breakup by Delivery Model:

On-premises

Hosted

Breakup by Application:

Training and Education

Consulting Services

Intraoperative Consultation

Routine Diagnostic Consultation Services

Others

Breakup by End-User:

Pharmaceutical & Biotechnology Companies

Hospitals and Reference Laboratories

Academic & Research Institutes

Breakup by Region:

North America

United States

Canada

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Asia Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Latin America

Brazil

Mexico

Argentina

Colombia

Chile

Peru

Others

Middle East and Africa

Turkey

Saudi Arabia

Iran

United Arab Emirates

Others

Competitive Landscape:

The report has also analysed the competitive landscape of the market with some of the key players being DHISTECH, Apollo Enterprise Imaging, Corista, Hamamatsu Photonics, Huron Digital Pathology, Indica Labs, Koninklijke Philips, Leica Biosystems, Objective Pathology Services, Ventana Medical Systems, Visiopharm and XIFIN, etc.

Key Questions Answered in This Report:

• How has the global digital pathology market performed so far and how will it perform in the coming years?
• What are the key regional markets in the global digital pathology industry?
• What has been the impact of COVID-19 on the global digital pathology market?
• What is the breakup of the market based on the product?
• What is the breakup of the market based on the type?
• What is the breakup of the market based on the delivery model?
• What is the breakup of the market based on the application?
• What is the breakup of the market based on the end-user?
• What are the various stages in the value chain of the industry?
• What are the key driving factors and challenges in the market?
• What is the structure of the global digital pathology industry and who are the key players?
• What is the degree of competition in the market?

Table of Contents

1 Preface

2 Scope and Methodology

• 2.1 Objectives of the Study
• 2.2 Stakeholders
• 2.3 Data Sources
  • 2.3.1 Primary Sources
  • 2.3.2 Secondary Sources
• 2.4 Market Estimation
  • 2.4.1 Bottom-Up Approach
  • 2.4.2 Top-Down Approach
• 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

• 4.1 Overview
• 4.2 Key Industry Trends

5 Global Digital Pathology Market

• 5.1 Market Overview
• 5.2 Market Performance
• 5.3 Impact of COVID-19
• 5.4 Market Forecast

6 Market Breakup by Product

• 6.1 Scanners
  • 6.1.1 Market Trends
  • 6.1.2 Market Forecast
• 6.2 Software
  • 6.2.1 Market Trends
  • 6.2.2 Market Forecast
• 6.3 Storage Systems
  • 6.3.1 Market Trends
  • 6.3.2 Market Forecast
• 6.4 Communication Systems
  • 6.4.1 Market Trends
  • 6.4.2 Market Forecast

7 Market Breakup by Type

• 7.1 Human Pathology
  • 7.1.1 Market Trends
  • 7.1.2 Market Forecast
• 7.2 Veterinary Pathology
  • 7.2.1 Market Trends
  • 7.2.2 Market Forecast

8 Market Breakup by Delivery Model

• 8.1 On-premises
  • 8.1.1 Market Trends
  • 8.1.2 Market Forecast
• 8.2 Hosted
  • 8.2.1 Market Trends
  • 8.2.2 Market Forecast

9 Market Breakup by Application

• 9.1 Training and Education
  • 9.1.1 Market Trends
  • 9.1.2 Market Forecast
• 9.2 Consulting Services
  • 9.2.1 Market Trends
  • 9.2.2 Market Forecast
• 9.3 Intraoperative Consultation
  • 9.3.1 Market Trends
  • 9.3.2 Market Forecast
• 9.4 Routine Diagnostic Consultation Services
  • 9.4.1 Market Trends
  • 9.4.2 Market Forecast
• 9.5 Others
  • 9.5.1 Market Trends
  • 9.5.2 Market Forecast

10 Market Breakup by End-User

• 10.1 Pharmaceutical & Biotechnology Companies
  • 10.1.1 Market Trends
  • 10.1.2 Market Forecast
• 10.2 Hospitals and Reference Laboratories
  • 10.2.1 Market Trends
  • 10.2.2 Market Forecast
• 10.3 Academic & Research Institutes
  • 10.3.1 Market Trends
  • 10.3.2 Market Forecast

11 Market Breakup by Region

• 11.1 North America
  • 11.1.1 United States
    • 11.1.1.1 Market Trends
    • 11.1.1.2 Market Forecast
  • 11.1.2 Canada
    • 11.1.2.1 Market Trends
    • 11.1.2.2 Market Forecast
• 11.2 Europe
  • 11.2.1 Germany
    • 11.2.1.1 Market Trends
    • 11.2.1.2 Market Forecast
  • 11.2.2 France
    • 11.2.2.1 Market Trends
    • 11.2.2.2 Market Forecast
  • 11.2.3 United Kingdom
    • 11.2.3.1 Market Trends
    • 11.2.3.2 Market Forecast
  • 11.2.4 Italy
    • 11.2.4.1 Market Trends
    • 11.2.4.2 Market Forecast
  • 11.2.5 Spain
    • 11.2.5.1 Market Trends
    • 11.2.5.2 Market Forecast
  • 11.2.6 Russia
    • 11.2.6.1 Market Trends
    • 11.2.6.2 Market Forecast
  • 11.2.7 Others
    • 11.2.7.1 Market Trends
    • 11.2.7.2 Market Forecast
• 11.3 Asia Pacific
  • 11.3.1 China
    • 11.3.1.1 Market Trends
    • 11.3.1.2 Market Forecast
  • 11.3.2 Japan
    • 11.3.2.1 Market Trends
    • 11.3.2.2 Market Forecast
  • 11.3.3 India
    • 11.3.3.1 Market Trends
    • 11.3.3.2 Market Forecast
  • 11.3.4 South Korea
    • 11.3.4.1 Market Trends
    • 11.3.4.2 Market Forecast
  • 11.3.5 Australia
    • 11.3.5.1 Market Trends
    • 11.3.5.2 Market Forecast
  • 11.3.6 Indonesia
    • 11.3.6.1 Market Trends
    • 11.3.6.2 Market Forecast
  • 11.3.7 Others
    • 11.3.7.1 Market Trends
    • 11.3.7.2 Market Forecast
• 11.4 Latin America
  • 11.4.1 Brazil
    • 11.4.1.1 Market Trends
    • 11.4.1.2 Market Forecast
  • 11.4.2 Mexico
    • 11.4.2.1 Market Trends
    • 11.4.2.2 Market Forecast
  • 11.4.3 Argentina
    • 11.4.3.1 Market Trends
    • 11.4.3.2 Market Forecast
  • 11.4.4 Colombia
    • 11.4.4.1 Market Trends
    • 11.4.4.2 Market Forecast
  • 11.4.5 Chile
    • 11.4.5.1 Market Trends
    • 11.4.5.2 Market Forecast
  • 11.4.6 Peru
    • 11.4.6.1 Market Trends
    • 11.4.6.2 Market Forecast
  • 11.4.7 Others
    • 11.4.7.1 Market Trends
    • 11.4.7.2 Market Forecast
• 11.5 Middle East and Africa
  • 11.5.1 Turkey
    • 11.5.1.1 Market Trends
    • 11.5.1.2 Market Forecast
  • 11.5.2 Saudi Arabia
    • 11.5.2.1 Market Trends
    • 11.5.2.2 Market Forecast
  • 11.5.3 Iran
    • 11.5.3.1 Market Trends
    • 11.5.3.2 Market Forecast
  • 11.5.4 United Arab Emirates
    • 11.5.4.1 Market Trends
    • 11.5.4.2 Market Forecast
  • 11.5.5 Others
    • 11.5.5.1 Market Trends
    • 11.5.5.2 Market Forecast

12 SWOT Analysis

• 12.1 Overview
• 12.2 Strengths
• 12.3 Weaknesses
• 12.4 Opportunities
• 12.5 Threats

13 Value Chain Analysis

14 Porters Five Forces Analysis

• 14.1 Overview
• 14.2 Bargaining Power of Buyers
• 14.3 Bargaining Power of Suppliers
• 14.4 Degree of Competition
• 14.5 Threat of New Entrants
• 14.6 Threat of Substitutes

15 Competitive Landscape

• 15.1 Market Structure
• 15.2 Key Players
• 15.3 Profiles of Key Players
  • 15.3.1 DHISTECH
    • 15.3.1.1 Company Overview
    • 15.3.1.2 Product Portfolio
  • 15.3.2 Apollo Enterprise Imaging
    • 15.3.2.1 Company Overview
    • 15.3.2.2 Product Portfolio
  • 15.3.3 Corista
    • 15.3.3.1 Company Overview
    • 15.3.3.2 Product Portfolio
  • 15.3.4 Hamamatsu Photonics
    • 15.3.4.1 Company Overview
    • 15.3.4.2 Product Portfolio
    • 15.3.4.3 Financials
  • 15.3.5 Huron Digital Pathology
    • 15.3.5.1 Company Overview
    • 15.3.5.2 Product Portfolio
  • 15.3.6 Indica Labs
    • 15.3.6.1 Company Overview
    • 15.3.6.2 Product Portfolio
  • 15.3.7 Koninklijke Philips
    • 15.3.7.1 Company Overview
    • 15.3.7.2 Product Portfolio
    • 15.3.7.3 Financials
    • 15.3.7.4 SWOT Analysis
  • 15.3.8 Leica Biosystems
    • 15.3.8.1 Company Overview
    • 15.3.8.2 Product Portfolio
  • 15.3.9 Objective Pathology Services
    • 15.3.9.1 Company Overview
    • 15.3.9.2 Product Portfolio
  • 15.3.10 Ventana Medical Systems
    • 15.3.10.1 Company Overview
    • 15.3.10.2 Product Portfolio
  • 15.3.11 Visiopharm
    • 15.3.11.1 Company Overview
    • 15.3.11.2 Product Portfolio
  • 15.3.12 XIFIN
    • 15.3.12.1 Company Overview
    • 15.3.12.2 Product Portfolio